Hemosphere, Inc., an Eden Prairie, MN-based medical device company, has completed a $9.3m round of venture capital financing.
The round was led by Kaiser Permanente Ventures, with new investor Mutual Capital Partners and previous investors including Affinity Capital Management, Sapient Capital, Cutlass Capital, and Ascension Health Ventures, also participating.
The additional capital will allow the company to market HeRO, a vascular access device providing access for hemodialysis – the process of filtering waste products from blood when kidneys are in renal failure. HeRO bypasses central venous damage caused by catheters and significantly reduces the risk of catheter related bacteremia, a potentially fatal infection.
FinSMEs
31/03/2010